糖化白蛋白临床研究进展  

Advances in clinical research on glycosylated albumin

作　　者：陈远东[1] 马玲娣[1] 杨海[1] 周晓云[1] 陈琼娣[1] CHEN Yuandong;MA Lingdi;YANG Hai;ZHOU Xiaoyun;CHEN Qiongdi(Huizhou Third People’s Hospital,Huizhou,Guangdong 516002,China)

机构地区：[1]惠州市第三人民医院,广东惠州516002

出　　处：《医药前沿》2021年第4期15-16,共2页Journal of Frontiers of Medicine

摘　　要：近几年来,我国糖尿病患者的总人数在不断地上升,它已经成为危害人们生命健康的重要疾病之一。然而,糖化白蛋白是有效检测血糖的重要内容,已经有很多的大型临床研究证实,糖化白蛋白与糖尿病慢性并发症的发生存在关联,它能有效将糖尿病患者的血糖水平控制在合适的范围内,从而有效降低慢性并发症的风险。In recent years,the total number of patients with diabetes in China is rising,it has become one of the important diseases that endanger people's life and health.However,glycosylated albumin is an important part of effective identification of blood glucose.Many large-scale clinical studies have confirmed that glycosylated albumin is associated with the occurrence of diabetic chronic complications.It can effectively control the blood glucose level of diabetic patients in an appropriate range,so as to effectively reduce the risk of chronic complications.

关 键 词：糖化白蛋白 临床研究 综述 

分 类 号：R587.1[医药卫生—内分泌]